The global muscle stimulator market is projected to grow from $812 million in 2025 to $1.16 billion by 2035, at a CAGR of 3.6%. Growth is fueled by increasing use of neuromuscular electrical stimulation devices for pain management, sports rehabilitation, physiotherapy, and home healthcare. North America leads the market, while Asia Pacific is the fastest-growing region due to expanding healthcare infrastructure and rising awareness. Key segments include Transcutaneous Electrical Nerve Stimulation (TENS) and portable devices, with pain management being the largest application. Major companies are innovating with advanced portable stimulators and wireless devices to meet rising demand.
An analyst from D.A. Davidson raised the price target for Taiwan Semiconductor Manufacturing Company (TSMC) to $500, indicating a 22% potential upside from its current price of $409.74. This upgrade is driven by strong demand in artificial intelligen...
Intuitive Surgical reported strong Q2 earnings with adjusted EPS of $2.80, surpassing analyst expectations due to high demand for its da Vinci robotic surgical systems. Despite the positive results, the stock dropped 12% in premarket trading after th...
Fifth Third Bancorp reported Q2 earnings per share of $0.83, slightly below estimates, but revenue exceeded expectations at $3.26 billion, driven by higher net interest income and strong fee growth in capital markets and wealth management. The bank s...
The global livestock monitoring market is expected to grow from $6.2 billion in 2025 to $10.3 billion by 2030, at a CAGR of 10.6%, fueled by the adoption of AI, IoT sensors, and wearable tech in precision farming. Europe leads with the largest market...
Atlas Healthcare Fund, managed by VST Capital, invested in Eli Lilly at around $350 per share in 2020, well before its GLP-1 drug tirzepatide became a major success. The stock now trades above $1,200, reflecting a gain of over 246%. This early invest...
